Folgen
Euan A. Ashley
Euan A. Ashley
Chair, Department of Medicine, Stanford University
Bestätigte E-Mail-Adresse bei stanford.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Guidelines for investigating causality of sequence variants in human disease
DG MacArthur, TA Manolio, DP Dimmock, HL Rehm, J Shendure, ...
Nature 508 (7497), 469-476, 2014
14512014
Personal omics profiling reveals dynamic molecular and medical phenotypes
R Chen, GI Mias, J Li-Pook-Than, L Jiang, HYK Lam, R Chen, E Miriami, ...
Cell 148 (6), 1293-1307, 2012
14352012
Artificial intelligence in cardiology
KW Johnson, J Torres Soto, BS Glicksberg, K Shameer, R Miotto, M Ali, ...
Journal of the American College of Cardiology 71 (23), 2668-2679, 2018
11542018
Towards precision medicine
EA Ashley
Nature Reviews Genetics 17 (9), 507-522, 2016
11162016
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
8512021
A long noncoding RNA protects the heart from pathological hypertrophy
P Han, W Li, CH Lin, J Yang, C Shang, ST Nurnberg, KK Jin, W Xu, ...
Nature 514 (7520), 102-106, 2014
8302014
Clinical assessment incorporating a personal genome
EA Ashley, AJ Butte, MT Wheeler, R Chen, TE Klein, FE Dewey, ...
The Lancet 375 (9725), 1525-1535, 2010
8212010
Video-based AI for beat-to-beat assessment of cardiac function
D Ouyang, B He, A Ghorbani, N Yuan, J Ebinger, CP Langlotz, ...
Nature 580 (7802), 252-256, 2020
8172020
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
N Sun, M Yazawa, J Liu, L Han, V Sanchez-Freire, OJ Abilez, ...
Science translational medicine 4 (130), 130ra47-130ra47, 2012
8012012
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells
F Lan, AS Lee, P Liang, V Sanchez-Freire, PK Nguyen, L Wang, L Han, ...
Cell stem cell 12 (1), 101-113, 2013
7642013
Electrocardiographic interpretation in athletes: the ‘Seattle criteria’
JA Drezner, MJ Ackerman, J Anderson, E Ashley, CA Asplund, ...
British journal of sports medicine 47 (3), 122-124, 2013
7562013
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ...
Circulation 138 (14), 1387-1398, 2018
7112018
Accuracy in wrist-worn, sensor-based measurements of heart rate and energy expenditure in a diverse cohort
A Shcherbina, CM Mattsson, D Waggott, H Salisbury, JW Christle, ...
Journal of personalized medicine 7 (2), 3, 2017
6762017
Deep learning automates the quantitative analysis of individual cells in live-cell imaging experiments
DA Van Valen, T Kudo, KM Lane, DN Macklin, NT Quach, MM DeFelice, ...
PLoS computational biology 12 (11), e1005177, 2016
6312016
The precision medicine initiative: a new national effort
EA Ashley
Jama 313 (21), 2119-2120, 2015
6312015
Chromatin regulation by Brg1 underlies heart muscle development and disease
CT Hang, J Yang, P Han, HL Cheng, C Shang, E Ashley, B Zhou, ...
Nature 466 (7302), 62-67, 2010
5522010
Clinical interpretation and implications of whole-genome sequencing
FE Dewey, ME Grove, C Pan, BA Goldstein, JA Bernstein, H Chaib, ...
Jama 311 (10), 1035-1045, 2014
5392014
The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo
EA Ashley, J Powers, M Chen, R Kundu, T Finsterbach, A Caffarelli, ...
Cardiovascular research 65 (1), 73-82, 2005
5372005
Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction
MM Chen, EA Ashley, DXF Deng, A Tsalenko, A Deng, R Tabibiazar, ...
Circulation 108 (12), 1432-1439, 2003
5192003
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis
HJ Chun, ZA Ali, Y Kojima, RK Kundu, AY Sheikh, R Agrawal, L Zheng, ...
The Journal of clinical investigation 118 (10), 3343-3354, 2008
4762008
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20